Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

February 4, 2026
Novo Nordisk is being more cautious on Medicare, says Mizuho’s HolzNovo Nordisk is being more cautious on Medicare, says Mizuho’s Holz
Share This

CNBC’s “Fast Money” team discusses why GLP-1 drugmaker stocks are diverging with Jared Holz of Mizuho.

‍

Latest Mizuho News

See all news
A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026
Why biotechnology stocks have more room to run

Why biotechnology stocks have more room to run

May 12, 2026
Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

May 8, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue